Apton’s innovative high-throughput and low-cost sequencing platform is enabled by a proprietary super-resolution, high-speed imaging system combined with unique, low-cost flow cells.  The system will help researchers decipher the molecular mechanisms of disease and guide physicians on treatment selections, enabling broad genomic applications for translational research, precision medicine and health screening.